| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.KINT.2017.08.013 |
| P8608 | Fatcat ID | release_5c35b55mrzazxn55hjesjsbjhu |
| P932 | PMC publication ID | 5794609 |
| P698 | PubMed publication ID | 29054530 |
| P50 | author | Matthias Kretzler | Q30004156 |
| P2093 | author name string | Jennifer L Harder | |
| Peter J Nelson | |||
| Wenjun Ju | |||
| Viji Nair | |||
| E Jennifer Weil | |||
| Robert G Nelson | |||
| Bradley Godfrey | |||
| Kevin V Lemley | |||
| Berne Yee | |||
| Carine M Boustany-Kari | |||
| Claudiu V Komorowsky | |||
| Jeffrey Hodgin | |||
| Margrit Schwarz | |||
| P2860 | cites work | WGCNA: an R package for weighted correlation network analysis | Q21284194 |
| Evolution of incipient nephropathy in type 2 diabetes mellitus | Q28145309 | ||
| US Renal Data System 2012 Annual Data Report | Q30582337 | ||
| NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus | Q33748565 | ||
| Integrative biology identifies shared transcriptional networks in CKD. | Q34427636 | ||
| Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury | Q34568811 | ||
| In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. | Q34669819 | ||
| Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort | Q34891831 | ||
| Transcriptome analysis of human diabetic kidney disease | Q35180096 | ||
| Tubulointerstitial changes as a major determinant in the progression of renal damage | Q36282631 | ||
| Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy | Q36319830 | ||
| Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli | Q36477207 | ||
| Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes | Q36661639 | ||
| Can we target tubular damage to prevent renal function decline in diabetes? | Q36677752 | ||
| How should renal hemodynamic data be indexed in obesity? | Q36707439 | ||
| Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker | Q36883839 | ||
| Temporal trends in the prevalence of diabetic kidney disease in the United States | Q37064114 | ||
| Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy | Q37066937 | ||
| Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. | Q37110523 | ||
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis | Q37166321 | ||
| The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes | Q37236230 | ||
| Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes | Q37364966 | ||
| Causal analysis approaches in Ingenuity Pathway Analysis | Q37592031 | ||
| Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. | Q37871339 | ||
| Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. | Q38136506 | ||
| Innate immunity in diabetes and diabetic nephropathy | Q38633495 | ||
| JAK inhibition in the treatment of diabetic kidney disease | Q38873515 | ||
| Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease. | Q38925521 | ||
| The lifetime cost of diabetes and its implications for diabetes prevention | Q39141376 | ||
| Suppressors of cytokine signaling abrogate diabetic nephropathy | Q39735007 | ||
| Role of NFAT5 in inflammatory disorders associated with osmotic stress | Q41990297 | ||
| Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration | Q43500228 | ||
| US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. | Q43779886 | ||
| Regression of microalbuminuria in type 1 diabetes | Q44467189 | ||
| Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. | Q44489763 | ||
| Modeling GFR trajectories in diabetic nephropathy | Q46495855 | ||
| Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. | Q53288801 | ||
| Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. | Q54559717 | ||
| Obesity, Glomerular Hyperfiltration, and the Surface Area Correction | Q60777213 | ||
| The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis | Q70225378 | ||
| Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus | Q73128414 | ||
| Glomerular hemodynamics in severe obesity | Q73782711 | ||
| Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application | Q77475022 | ||
| Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy | Q79301271 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-10-18 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. |
| Q89641922 | A Functional Landscape of CKD Entities From Public Transcriptomic Data |
| Q64125373 | A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes |
| Q57189950 | An integrative systems biology approach for precision medicine in diabetic kidney disease |
| Q90605212 | Artificial intelligence driven next-generation renal histomorphometry |
| Q52589075 | CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. |
| Q90439858 | Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression |
| Q56982064 | Human Glomerular Transcriptome of Diabetic Kidneys: Can Podocyte Cytoskeleton be Therapeutic Target? |
| Q92884447 | Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney disease |
| Q95328312 | Integrated multi-omics approaches to improve classification of chronic kidney disease |
| Q55476169 | Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease. |
Search more.